PRODUCT DESCRIPTION

Tilmicosin 30% Injection Veterinary Medicine Drugs For Sheep Cattle Swine Poultry

Description of Tilmicosin injection 30% :

Tilmicosin is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Gram-positive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.

Indication of Tilmicosin injection 30% :

For first-line control and treatment of Bovine Respiratory Disease (BRD). Also used for the treatment of respiratory bacterial diseases in large ruminants, caused by Pasteurella miltocida, Mannheimia (Pasteurella) haemolytica, infection processes associated with Haemophilus somnus, Histophilus spp. etc.

Contra indications of Tilmicosin injection 30% :

Hypersensitivity or resistance to tilmicosin.

Concurrent administration of other macrolides or lincosamides.

Administration to animals with an active microbial digestion or to equine or caprine species.

Parenteral administration, especially in porcine species.

Administration to poultry producing eggs for human consumption or to animals intended for breeding purposes.

During pregnancy and lactation, use only after a risk/benefit assessment by a veterinarian.